tradingkey.logo

Bio Rad Laboratories Inc

BIO

284.600USD

+42.650+17.63%
Close 08/01, 16:00ETQuotes delayed by 15 min
7.86BMarket Cap
LossP/E TTM

Bio Rad Laboratories Inc

284.600

+42.650+17.63%
More Details of Bio Rad Laboratories Inc Company
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Company Info
Ticker SymbolBIO
Company nameBio Rad Laboratories Inc
IPO dateMar 17, 1980
Founded at1975
CEOMr. Norman D. Schwartz
Number of employees7700
Security typeOrdinary Share
Fiscal year-endMar 17
Address1000 Alfred Nobel Dr
CityHERCULES
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code94547
Phone15107247000
Websitehttps://www.bio-rad.com/
Ticker SymbolBIO
IPO dateMar 17, 1980
Founded at1975
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
442.79K
+0.49%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
18.48K
+7.29%
Mr. Michael Crowley
Mr. Michael Crowley
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
8.17K
--
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
729.00
+3545.00%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
308.00
--
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
157.00
--
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
119.00
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
442.79K
+0.49%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
18.48K
+7.29%
Mr. Michael Crowley
Mr. Michael Crowley
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
8.17K
--
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+61.60%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
729.00
+3545.00%
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
United States
241.70M
41.29%
Europe
199.80M
34.13%
APAC
104.10M
17.78%
Other
39.80M
6.80%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
First Eagle Investment Management, L.L.C.
10.36%
The Vanguard Group, Inc.
8.59%
Alice N. Schwartz Revocable Trust
8.04%
BlackRock Institutional Trust Company, N.A.
7.42%
Schwartz (Alice N)
4.29%
Other
61.29%
Shareholders
Shareholders
Proportion
First Eagle Investment Management, L.L.C.
10.36%
The Vanguard Group, Inc.
8.59%
Alice N. Schwartz Revocable Trust
8.04%
BlackRock Institutional Trust Company, N.A.
7.42%
Schwartz (Alice N)
4.29%
Other
61.29%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
42.73%
Investment Advisor
39.24%
Individual Investor
8.14%
Corporation
8.05%
Hedge Fund
5.69%
Research Firm
1.93%
Bank and Trust
1.28%
Pension Fund
1.16%
Sovereign Wealth Fund
0.64%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
1114
24.05M
108.63%
-2.78M
2025Q1
1170
23.54M
106.01%
-2.87M
2024Q4
1159
23.02M
100.37%
-3.90M
2024Q3
1144
23.65M
103.58%
-2.77M
2024Q2
1163
23.92M
102.32%
-878.39K
2024Q1
1175
22.36M
95.71%
-2.57M
2023Q4
1205
22.70M
94.11%
-2.35M
2023Q3
1189
22.91M
95.16%
-1.86M
2023Q2
1192
23.05M
93.93%
-1.30M
2023Q1
1200
23.34M
95.18%
-1.09M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
First Eagle Investment Management, L.L.C.
2.29M
10.36%
+728.07K
+46.49%
Apr 30, 2025
The Vanguard Group, Inc.
1.90M
8.59%
-10.12K
-0.53%
Mar 31, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.04%
-3.19K
-0.18%
Feb 24, 2025
BlackRock Institutional Trust Company, N.A.
1.64M
7.42%
-4.83K
-0.29%
Mar 31, 2025
Schwartz (Alice N)
951.13K
4.3%
+2.20K
+0.23%
Feb 24, 2025
Veritas Asset Management LLP
913.12K
4.12%
-63.70K
-6.52%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
877.04K
3.96%
+130.92K
+17.55%
Mar 31, 2025
Ariel Investments, LLC
724.66K
3.27%
+164.14K
+29.28%
Mar 31, 2025
State Street Global Advisors (US)
694.52K
3.14%
+4.36K
+0.63%
Mar 31, 2025
EARNEST Partners, LLC
599.62K
2.71%
-18.43K
-2.98%
Mar 31, 2025
View more
Related ETFs
Updated: 11 hours ago
Updated: 11 hours ago
Name
Proportion
Parnassus Value Select ETF
2.78%
VanEck Morningstar ESG Moat ETF
2.29%
First Trust Indxx Medical Devices ETF
1.89%
Alger Russell Innovation ETF
1.78%
ROBO Global Healthcare Technology & Innovation ETF
1.57%
VanEck Morningstar Wide Moat Growth ETF
1.16%
Schwab Ariel Opportunities ETF
1.14%
Pacer US Export Leaders ETF
1.02%
FPA Global Equity ETF
1.01%
First Eagle Global Equity ETF
0.84%
View more
Parnassus Value Select ETF
Proportion2.78%
VanEck Morningstar ESG Moat ETF
Proportion2.29%
First Trust Indxx Medical Devices ETF
Proportion1.89%
Alger Russell Innovation ETF
Proportion1.78%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.57%
VanEck Morningstar Wide Moat Growth ETF
Proportion1.16%
Schwab Ariel Opportunities ETF
Proportion1.14%
Pacer US Export Leaders ETF
Proportion1.02%
FPA Global Equity ETF
Proportion1.01%
First Eagle Global Equity ETF
Proportion0.84%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI